Serpina3c overexpression, Hif1α knockdown, and glycolysis inhibition, along with alleviated adipocyte hypertrophy and decreased lipid content, collectively indicate that Serpina3c improves hypertriglyceridemia via the Hif1α/glycolysis pathway. Here, HIF1A is linked to hypertriglyceridemia.